Sarah H. O'Brien, MD :: Nationwide Children’s Hospital, Columbus, Ohio

Contact Information

Hematology & Oncology
700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 722-3550
FX: (614) 722-8826
Email Me
The Research Institute at Nationwide Children's Hospital
700 Children's Drive
Columbus, Ohio 43205 [ map ]
FX: (614) 722.3544

Biography

Dr. O’Brien’s clinical and research interests include pediatric thrombosis and thromboprophylaxis, the evaluation and diagnosis of mild bleeding disorders, and the intersections between hematology and women’s health. She also leads a multidisciplinary hematology and adolescent gynecology clinic at Nationwide Children’s. As a health services researcher, Dr. O’Brien has a particular interest in the use of large administrative databases, as well as decision analysis and cost effectiveness analysis. She attended the University of Pittsburgh School of Medicine and received her residency and fellowship training from Children’s Hospital of Pittsburgh of UPMC. Dr. O’Brien is voted among the “Best Doctors in America”.

View CV »

Gender:

  • Female

Languages Spoken:

  • English

Clinical Interests

  • Iron deficiency in adolescents
  • Evaluation of bleeding disorders
  • Heavy menstrual bleeding
  • ITP
  • Thrombosis

Research Interests

Research Center:

Areas of Interest:

  • Menorrhagia in adolescents
  • Mild bleeding disorders
  • Iron deficiency in adolescent females
  • Quality of care in sickle cell anemia
  • New anticoagulants in pediatrics
  • Management of pediatric ITP
  • Thromboprophylaxis Evaluation

Research Funding*:

  • 4-week, open label, multiple-dose study of the safety and the pharmacokinetic and pharmacodynamic properties of the oral direct factor Xa inhibitor rivroxaban in pediatric subjects with venous thromboembolism
  • Phase I/II Infrastructure Grant
  • Comprehensive Sickle Cell Treatment Center
  • DVT Prevention in Pediatric and Adolescent Trauma Patients: Safety and Costs
  • Thrombophilia Screening in Children with Venous Thromboembolism: Cost-Effectiveness Analysis

Education and Training

Medical School

  • University of Pittsburgh School of Medicine
    Date Completed: 05/31/2000

Residency

  • Children's Hospital of Pittsburgh of UPMC
    Date Completed: 06/30/2003

Graduate School

  • University of Pittsburgh
    Date Completed: 06/30/2006

Fellowship

  • Children's Hospital of Pittsburgh of UPMC
    Date Completed: 07/31/2006

Department:

  • Pediatrics

Section:

  • Hematology & Oncology

Specialty:

  • Pediatric Hematology Oncology

Date of Appointment at Nationwide Children’s Hospital:

  • 09/29/2006

Professional Experience

2013–present

  • Director of Experimental Therapeutics, Section of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Columbus, OH

2013–present

  • Associate Professor, Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Columbus, OH

2006–present

  • Investigator, Center for Innovation in Pediatric Practice, The Research Institute at Nationwide Children's Hospital, Columbus, OH

2006–2013

  • Assistant Professor, Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Columbus, OH

2003–2006

  • Pediatric Hematology/Oncology Fellowship, Children's Hospital of Pittsburgh, Pittsburgh, PA

2000–2003

  • Pediatric Residency, Children's Hospital of Pittsburgh, Pittsburgh, PA

Publications

  • Khamees D, Klima J, O'Brien SH. 2015. Population Screening for Von Willegrand Disease in Adolescents with Heavy Menstrual Bleeding.  J Pediatr. Vol. 166, no. 1. (January): 195-7.
  • Kerlin BA, Stephens JA, HOgan MJ, Smoyer WE, O'Brien SH. 2014. Development of a Pediatric-Specific Clinical Probability Tool for Diagnosis of Venous Thromboembolism: A feasibility Study.  Pediatr Res. Vol. Epub ahead of print, no. December: e..
  • Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA. 2014. Five hematologic tests and treatments to question.  Blood. Vol. 124, no. 24. (December): 3524-8.
  • Lang,A,T; Sturm,M,S; Koch,T; Walsh,M; Grooms,L,P; O'Brien,S,H. 2014. The accuracy of a patient or parent-administered bleeding assessment tool administered in a paediatric haematology clinic.  HAEMOPHILIA. Vol. 20, no. 6. (November): 807-813.
  • O'Brien,S,H; Kulkarni,R; WALLACE,A; Hamblin,F; Burr,S; Goldenberg,N,A. 2014. Multicenter dose-finding and efficacy and safety outcomes in neonates and children treated with dalteparin for acute venous thromboembolism.  JOURNAL OF THROMBOSIS AND HAEMOSTASIS. Vol. 12, no. 11. (November): 1822-1825.
  • Zia A, O'Brien SH. 2014. Global coagulation assays: a clinical perspective.  J Thromb Thrombolysis. Vol. Epub ahead of print., no. September: e..
  • Faustino EV, Hanson S, Spinella PC, Tucci M, O'Brien SH, Nunez AR, Yung M, Truemper E, Qin L, Li S, Marohn K, Randolph AG. 2014. A multinational study of thromboprophylaxis practice in critically ill children.  Crit Care Med. Vol. 42, no. 5. (May): 1232-40.
  • O'Brien,Sarah,H. 2014. Contraception-related venous thromboembolism in adolescents.  Seminars in thrombosis and hemostasis. Vol. 40, no. 1. (February): 66-71.
  • Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA. 2013. The ASH Choosing Wisely campaign: five hematologic tests and treatments to question.  Hematology AM SOC Hematol Educ Program. Vol. 2013, no. December: 9-14.
  • Hicks,Lisa,K; Bering,Harriet; Carson,Kenneth,R; Kleinerman,Judith; Kukreti,Vishal; Ma,Alice; Mueller,Brigitta,U; O'Brien,Sarah,H; Pasquini,Marcelo; Sarode,Ravindra; Solberg,Lawrence; Haynes,Adam,E; Crowther,Mark,A. 2013. The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question.  Blood. Vol. 122, no. 24. (December): 3879-3883.
  • Yee,Donald,L; O'Brien,Sarah,H; Young,Guy. 2013. Pharmacokinetics and Pharmacodynamics of Anticoagulants in Paediatric Patients.  CLINICAL PHARMACOKINETICS. Vol. 52, no. 11. (November): 967-980.
  • Thompson,Joel,C; Klima,Jennifer; Despotovic,Jenny,M; O'Brien,Sarah,H. 2013. Anti-D Immunoglobulin Therapy for Pediatric ITP: Before and After the FDA's Black Box Warning.  PEDIATRIC BLOOD & CANCER. Vol. 60, no. 11. (November): E149-E151.
  • Pillai,Prasanth; Bonny,Andrea,E; O'Brien,Sarah,H. 2013. Contraception-Related Venous Thromboembolism in a Pediatric Institution.  JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY. Vol. 26, no. 3. (June): 186-188.
  • Kime,Courtney; Klima,Jennifer; Rose,Melissa,J; O'Brien,Sarah,H. 2013. Patterns of Inpatient Care for Newly Diagnosed Immune Thrombocytopenia in US Children's Hospitals.  PEDIATRICS. Vol. 131, no. 5. (May): 880-885.
  • Wang,W; Bourgeois,T; Klima,J; Berlan,E,D; Fischer,A,N; O'Brien,S,H. 2013. Iron deficiency and fatigue in adolescent females with heavy menstrual bleeding.  HAEMOPHILIA. Vol. 19, no. 2. (March): 225-230.
  • Audino AN, Yeager ND, Asti L, Miao Y, O'Brien SH. 2013. Length of stay and treatment-related complications are similar in pediatric and AYA patients with bone sarcoma in United States children's hospitals.  Pediatr Blood Cancer. Vol. 60, no. 3. (March): 415-9.
  • Vo KT, Grooms L, Klima J, Holland-Hall C, O'Brien SH. 2013. Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent hematology clinic.  Haemophilia. Vol. 19, no. 1. (January): 71-75.
  • Kelly C, Rivard L, Salvi S, Hayani A, Hopkins W, O'Brien SH, et al. 2013. Surveillance following head, neck and chest radiotherapy: thyroid ultrasound monitoring for secondary thyroid malignancy.  Pediatr Blood Cancer. Vol. 60, no. 1. (January): 140-2.
  • Ragni MV, O'Brien SH. 2013. Women's Health Issues in Hematology. In American Society of Hematology Self Assessment Program 5th Edition. .: ..
  • Bercovitz,Rachel,S; O'Brien,Sarah,H. 2012. Measuring bleeding as an outcome in clinical trials of prophylactic platelet transfusions.  HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM. Vol. 1, no. December: 157-160.
  • Plocharczyk,Elizabeth,F; O'Brien,Sarah,H; Crumbacher,Jill,L; Kahwash,Samir,B. 2012. Platelet hyperreactivity: report of a case with catastrophic arterial thrombosis in a child.  Laboratory hematology : official publication of the International Society for Laboratory Hematology. Vol. 18, no. 4. (December): 22-26.
  • O'Brien,Sarah,H. 2012. Bleeding scores: are they really useful?.  HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM. Vol. ., no. December: 152-156.
  • O'Brien SH. 0. Bleeding scores: are they really useful?. In American Society of Hematology Annual Meeting
  • O'Brien SH. 2012. Common management issues in pediatric patients with mild bleeding disorders.  Semin Thromb Hemost. Vol. 38, no. 7. (October): 720-6.
  • O'Brien SH. 2012. Recognition and management of pediatric venous thromboembolism in the emergency department.  Clin Pediatr Emerg Med. Vol. 12, no. 3. (September): 185-190.
  • Setty B, O'Brien SH, Kerlin BA. 2012. Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases.  Pediatr Blood Cancer. Vol. 59, no. 2. (August): 258-64.
  • SLADKY,J,L; Klima,J; Grooms,L; Kerlin,B,A; O'Brien,S,H. 2012. The PFA-100 (R) does not predict delta-granule platelet storage pool deficiencies.  HAEMOPHILIA. Vol. 18, no. 4. (July): 626-629.
  • O'Brien SH, Klima J, Termuhlen AM, Kelleher KJ. 2012. Venous thromboembolism and adolescent and young adult oncology inpatients in US children's hospitals, 2001 to 2008.  J Pediatr. Vol. 159, no. 1. (July): 133-7.
  • Pillai,Prasanth; Bonny,Andrea; O'Brien,Sarah. 2012. CONTRACEPTION-RELATED VENOUS THROMBOEMBOLISM IN A PEDIATRIC INSTITUTION.  PEDIATRIC BLOOD & CANCER. Vol. 58, no. 7. (July): 1033-1034.
  • Sladky JL, Klima J, Grooms L, Kerlin BA, O'Brien SH. 2012. The PFA-100 does not predict delta-granule platelet storage pool deficiencies.  Haemophilia. Vol. 18, no. 4. (July): 626-9.
  • O'Brien,Sarah,H. 2012. An update on pediatric bleeding disorders: Bleeding scores, benign joint hypermobility, and platelet function testing in the evaluation of the child with bleeding symptoms.  AMERICAN JOURNAL OF HEMATOLOGY. Vol. 87, no. May: S40-S44.
  • Askegard-Giesmann JR, O'Brien SH, Wang W, Kenney BD. 2012. Increased utilization for enoxaparin in pediatric trauma patients.  J Pediatr Surg. Vol. 47, no. 5. (May): 980-3.
  • Askegard-Giesmann,Johanna,R; O'Brien,Sarah,H; Wang,Wei; Kenney,Brian,D. 2012. Increased use of enoxaparin in pediatric trauma patients. In 43rd Annual Meeting of the Canadian-Association-of-Paediatric-Surgeons (CAPS)
  • Dickerson AK, Klima J, Rhodes MM, O'Brien SH. 2012. Young adult with SCD in US children's hospitals: are they different from adolescents?.  Pediatr Blood Cancer. Vol. 58, no. 5. (May): 741-5.
  • O'Brien SH, Klima J, Gaines BA, Betz S, Zenati MS. 2012. Utilization of low molecular weight heparin prophylaxis in pediatric and adolescent trauma patients.  J Trauma Nurs.. Vol. 19, no. 2. (February): 117-21.
  • Young,Guy; Yee,Donald,L; O'Brien,Sarah,H; Khanna,Rachna; Barbour,April; Nugent,Diane,J. 2011. FondaKIDS: A Prospective Pharmacokinetic and Safety Study of Fondaparinux in Children Between 1 and 18 Years of Age.  PEDIATRIC BLOOD & CANCER. Vol. 57, no. 6. (December): 1049-1054.
  • Young G, Yee DL, O'Brien SH, Khanna R, et al. 2011. FondaKIDS: A prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age.  Pediatr Blood Cancer. Vol. 57, no. 6. (December): 1049-1054.
  • O'Brien,Sarah,H; Klima,Jennifer; Termuhlen,Amanda,M; Kelleher,Kelly,J. 2011. Venous Thromboembolism and Adolescent and Young Adult Oncology Inpatients in US Children's Hospitals, 2001 to 2008.  JOURNAL OF PEDIATRICS. Vol. 159, no. 1. (July): 133-137.
  • O'Brien,Sarah,H; Candrilli,Sean,D. 2011. In the absence of a central venous catheter, risk of venous thromboembolism is low in critically injured children, adolescents, and young adults: Evidence from the National Trauma Data Bank.  PEDIATRIC CRITICAL CARE MEDICINE. Vol. 12, no. 3. (May): 251-256.
  • O'Brien SH, Candrilli SD. 2011. In the absence of a central venous catheter, risk ofvenous thromboembolism is low in critically injured children, adolescents, andyoung adults: evidence from the National Trauma Data Bank.  Pediatric Critical Care Medicine. Vol. 12, no. 3. (May): 251-256.
  • Candrilli,Sean,D; O'Brien,Sarah,H; Ware,Russell,E; Nahata,Milap,C; Seiber,Eric,E; Balkrishnan,Rajesh. 2011. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease.  AMERICAN JOURNAL OF HEMATOLOGY. Vol. 86, no. 3. (March): 273-277.
  • Candrilli SD, O'Brien SH, Ware RE, Nahata MC, Seiber EE, Balkrishnan RB. 2011. Hydroxyurea Adherence and Associated Outcomes in Medicaid Enrollees with Sickle Cell Disease.  American Journal of Hematology. Vol. 86, no. 3. (March): 273-277.
  • Marcus,P,D; Nire,K,G; Grooms,L; Klima,J; O'Brien,S,H. 2011. The power of a standardized bleeding score in diagnosing paediatric type 1 von Willebrand's disease and platelet function defects.  HAEMOPHILIA. Vol. 17, no. 2. (March): 223-227.
  • Marcus PD, Nire KG, Grooms L, Klima J, O'Brien SH. 2011. The power of a standardized bleeding score in diagnosing pediatric type 1 Von Willebrand disease and platelet function defects.  Haemophilia. Vol. 17, no. 2. (March): 223-227.
  • O'Brien,Sarah,H; Klima,Jennifer; Reed,Suzanne; Chisolm,Deena; Schwarz,Eleanor,B; Kelleher,Kelly,J. 2011. Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims.  CONTRACEPTION. Vol. 83, no. 2. (February): 134-137.
  • Young G, Yee DL, O'Brien SH, Khanna R, Barbour A, Nugent DJ. 2011. FondaKIDS: A prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age.  Pediatric Blood & Cancer.
  • O'Brien SH, Klima J, Reed S, Chisolm D, Schwarz EB, Kelleher KJ. 2011. Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims.  Contraception. Vol. 83, no. 2. (February): 134-137.
  • Bollinger,Lindsay,M; Nire,Kidan,G; Rhodes,Melissa,M; Chisolm,Deena,J; O'Brien,Sarah,H. 2011. Caregivers' Perspectives on Barriers to Transcranial Doppler Screening in Children With Sickle-Cell Disease.  PEDIATRIC BLOOD & CANCER. Vol. 56, no. 1. (January): 99-102.
  • Bollinger LM, Nire KG, Rhodes M, Chisolm D, O'Brien SH. 2011. Caregivers' perspectives on barriers to transcranial doppler screening in children with sickle cell disease.  Pediatric Blood & Cancer. Vol. 56, no. 1. (January): 99-102.
  • O'Brien,Sarah,H; Cavo,Matthew; Wang,Wei. 2010. Use of low molecular weight heparin for thromboprophylaxis in a pediatric inpatient population: Reasons for use and incidence of bleeding complications.  THROMBOSIS RESEARCH. Vol. 125, no. 4. (April): 370-372.
  • O'Brien SH, Fan L, Kelleher KJ. 2010. Inpatient use of laxatives during opioid administration in children with sickle cell disease.  Pediatric Blood & Cancer. Vol. 54, no. 4. (April): 559-562.
  • Cavo M, Wang W, O'Brien SH. 2010. Use of low molecular weight heparin for thromboprophylaxis in a pediatric inpatient population: reasons for use and incidence of bleeding complications.  Thrombosis Research. Vol. 125, no. 4. (April): 370-372.
  • O'Brien,Sarah,H; Fan,Ling; Kelleher,Kelly,J. 2010. Inpatient Use of Laxatives During Opioid Administration in Children With Sickle Cell Disease.  PEDIATRIC BLOOD & CANCER. Vol. 54, no. 4. (April): 559-562.
  • O'Brien,Sarah,H; Hankins,Jane,S. 2009. Decision Analysis of Treatment Strategies in Children With Severe Sickle Cell Disease.  JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. Vol. 31, no. 11. (November): 873-878.
  • Candrilli,Sean,D; O'Brien,Sarah; Ware,Russell,E; Balkrishnan,Rajesh. 2009. Hydroxyurea Adherence and Associated Outcomes in Medicaid Enrollees with Sickle Cell Disease. In 51st Annual Meeting and Exposition of the American-Society-of-Hematology
  • O'Brien SH, Hankins JS. 2009. Decision analysis of treatment strategies in children with severe sickle cell disease.  Journal Of Pediatric Hematology/Oncology. Vol. 31, no. 11. (November): 873-878.
  • Candrilli,S,D; Davis,K,L; Balkrishnan,R; O'Brien,S. 2009. CHANGES IN RATES OF SICKLE CELL DISEASE-RELATED INPATIENT STAYS AND ASSOCIATED RESOURCE USE AMONG AFRICAN AMERICANS IN THE UNITED STATES FOLLOWING APPROVAL OF HYDROXYUREA.
  • Candrilli,Sean,D; Balkrishnan,Rajesh; O'Brien,Sarah,H. 2009. Effect of injury severity on the incidence and utilization-related outcomes of venous thromboembolism in pediatric trauma inpatients. In 13th Annual International Meeting of the International-Society-of-Pharmacoeconomics-and-Outcomes-Research
  • Candrilli,Sean,D; Balkrishnan,Rajesh; O'Brien,Sarah,H. 2009. Effect of injury severity on the incidence and utilization-related outcomes of venous thromboembolism in pediatric trauma inpatients. In 13th Annual International Meeting of the International-Society-of-Pharmacoeconomics-and-Outcomes-Research
  • Candrilli,Sean,D; Balkrishnan,Rajesh; O'Brien,Sarah,H. 2009. Effect of injury severity on the incidence and utilization-related outcomes of venous thromboembolism in pediatric trauma inpatients.  PEDIATRIC CRITICAL CARE MEDICINE. Vol. 10, no. 5. (September): 554-557.
  • Candrilli SD, Balkrishnan R, O'Brien SH. 2009. Effect of injury severity on the incidence and utilization-related outcomes of venous thromboembolism in pediatric trauma inpatients.  Pediatric Critical Care Medicine. Vol. 10, no. 5. (September): 554-557.
  • O'Brien,Sarah,H. 2009. Secondary Data Demonstrate Safety of Splenectomy in Spherocytosis.  PEDIATRIC BLOOD & CANCER. Vol. 52, no. 7. (July): 753-754.
  • O'Brien,Sarah,H; Smith,Kenneth,J. 2009. Using Thrombophilia Testing to Determine Anticoagulation Duration in Pediatric Thrombosis is not Cost-Effective.  JOURNAL OF PEDIATRICS. Vol. 155, no. 1. (July): 100-104.
  • O'Brien SH. 2009. Secondary data demonstrate safety of splenectomy in spherocytosis.  Pediatric Blood & Cancer. Vol. 52, no. 7. (July): 753-754.
  • O'Brien SH; Smith KJ. 2009. Using thrombophilia testing to determine anticoagulation duration in pediatric thrombosis is not cost-effective.  Journal Of Pediatrics. Vol. 155, no. 1. (July): 100-104.
  • O'Brien,Sarah,H; Smith,Kenneth,J. 2009. Using Thrombophilia Testing to Determine Anticoagulation Duration in Pediatric Thrombosis is not Cost-Effective. In 49th Annual Meeting of the American-Society-of-Hematology
  • Ritchey AK, Keller FG, O'Brien SH. 2009. Hematologic Manifestations of Childhood Illness. In Hematology: Basic Principles and Practice, 5th Edition. Edited by Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silverstein LE, McGlave P. New York: Elsevier, Churchill Livingstone.
  • Hyatt SA, Wang W, Kerlin BA, O'Brien SH. 2009. Applying diagnostic criteria for type 1 von Willebrand disease to a pediatric population.  Pediatric Blood & Cancer. Vol. 52, no. 1. (January): 102-107.
  • Hyatt,Sarah,A; Wang,Wei; Kerlin,Bryce,A; O'Brien,Sarah,H. 2009. Applying Diagnostic Criteria for Type 1 von Willebrand Disease to a Pediatric Population.  PEDIATRIC BLOOD & CANCER. Vol. 52, no. 1. (January): 102-107.
  • Standridge,Shannon,M; O'Brien,Sarah,H. 2008. Idiopathic Intracranial Hypertension in a Pediatric Population: A Retrospective Analysis of the Initial Imaging Evaluation.  JOURNAL OF CHILD NEUROLOGY. Vol. 23, no. 11. (November): 1308-1311.
  • Standridge SM, O'Brien SH. 2008. Idiopathic intracranial hypertension in a pediatric population: a retrospective analysis of the initial imaging evaluation.  Journal Of Child Neurology. Vol. 23, no. 11. (November): 1308-1311.
  • Candrilli,S,D; Balkrishnan,R; O'Brien,S. 2008. The effect of injury severity on the incidence and resource utilization-related outcomes of deep vein thrombosis among pediatric trauma admissions in the United States.
  • O'Brien SH. 2008. Decision analysis in pediatric hematology.  Pediatric Clinics Of North America. Vol. 55, no. 2. (April): 287-304.
  • O'Brien,Sarah,H; Haley,Kathy; Kelleher,Kelly,J; Wang,Wei; McKenna,Christine; Gaines,Barbara,A. 2008. Variation in DVT prophylaxis for adolescent trauma patients: a survey of the Society of Trauma Nurses.  Journal of trauma nursing : the official journal of the Society of Trauma Nurses. Vol. 15, no. 2. (April): 53-57.
  • O'Brien,Sarah,H; Kaizar,Eloise,E; Gold,Melanie,A; Kelleher,Kelly,J. 2008. Trends in prescribing patterns of hormonal contraceptives for adolescents.  CONTRACEPTION. Vol. 77, no. 4. (April): 264-269.
  • O'Brien SH, Kaizar EE, Gold MA, Kelleher KJ. 2008. Trends in prescribing patterns of hormonal contraceptives for adolescents.  Contraception. Vol. 77, no. 4. (April): 264-269.
  • O'Brien,Sarah,H. 2008. Decision analysis in pediatric hematology.  PEDIATRIC CLINICS OF NORTH AMERICA. Vol. 55, no. 2. (April): 287-?.
  • O'Brien SH, Haley K, Kelleher KJ, Wang W, McKenna C, Gaines BA. 2008. Variation in DVT prophylaxis for adolescent trauma patients: a survey of the Society of Trauma Nurses.  Journal Of Trauma Nursing. Vol. 15, no. 2. (January): 53-57.
  • O'Brien,Sarah,H; Smith,Kenneth,J. 2007. Universal thrombophilia screening not cost-effective for determining duration of anticoagulation in pediatric patients. In 49th Annual Meeting of the American-Society-of-Hematology
  • O'Brien SH, Lee H, Ritchey AK. 2007. Once-daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics study.  Journal Of Thrombosis And Haemostasis. Vol. 5, no. 9. (September): 1985-1987.
  • O Brien,S,H; LEE,H; Ritchey,A,K. 2007. Once-daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics study(1).  JOURNAL OF THROMBOSIS AND HAEMOSTASIS. Vol. 5, no. 9. (September): 1985-1987.
  • Lampel,Heather,P; Patel,Nisha; Boyse,Kathryn; O'Brien,Sarah,H; Zirwas,Matthew,J. 2007. Prevalence of hand dermatitis in inpatient nurses at a United States hospital.  DERMATITIS. Vol. 18, no. 3. (September): 140-142.
  • Lampel HP, Patel N, Boyse K, O'Brien SH, Zirwas MJ. 2007. Prevalence of hand dermatitis in inpatient nurses at a United States hospital.  Dermatitis. Vol. 18, no. 3. (September): 140-142.
  • Lee,Peggy,Lin; Lemos,Bianca; O'Brien,Sarah,H; English,Joseph,C; Zirwas,Matthew,J. 2007. Cutaneous diphtheroid infection and review of other cutaneous Gram-positive Bacillus infections.  Dermatitis. Vol. 79, no. 5. (May): 371-377.
  • O'Brien,Sarah,H; Ritchey,A,Kim; Smith,Kenneth,J. 2007. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).  PEDIATRIC BLOOD & CANCER. Vol. 48, no. 2. (February): 173-180.
  • O'Brien SH, Ritchey AK, Smith KJ. 2007. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).  Pediatric Blood & Cancer. Vol. 48, no. 2. (January): 173-180.
  • Lee PL, Lemos B, O’Brien SH, English JC, Zirwas MJ. 2007. Cutaneous diphtheroid infection and review of other cutaneous gram-positive bacillus infections.  Dermatitis. Vol. 79, no. 5. (January): 371-377.
  • O'Brien,S,H; Ritchey,A,K; Ragni,M,V. 2007. Combined clotting factor deficiencies: experience at a single hemophilia treatment center.  HAEMOPHILIA. Vol. 13, no. 1. (January): 26-29.
  • O'Brien SH, Ritchey AK, Ragni MV. 2007. Combined clotting factor deficiencies: experience at a single hemophilia treatment center.  Haemophilia. Vol. 13, no. 1. (January): 26-29.
  • O'Brien SH, Holubkov R, Reis EC. 2004. Identification, evaluation, and management of obesity in an academic primary care center.  Pediatrics. Vol. 114, no. 2. (August): e154-e159.
  • O'Brien,Sarah,Harvey; Holubkov,Richard; Reis,Evelyn,Cohen. 2004. Identification, evaluation, and management of obesity in an academic primary care center.  Pediatrics. Vol. 114, no. 2. (August): e154-9.
  • O'Brien S, Holtzer K. 2003. Hematology/Oncology. In Pediatrics in a Page. Edited by Kahan S, DeAntonis K.. Oxford: Blackwell Publishing.

Awards, Honors and Organizations

  • Member, American Society of Hematology, 2003-Present
  • Member, American Society of Pediatric Hematology/Oncology, 2004-Present
  • Member, Hemophilia and Thrombosis Research Society, 2004-Present
  • Member, Children's Oncology Group, 2001-Present
  • Faculty Leadership Institute, The Ohio State University Wexner Medical Center, 2013-14
  • Eberhard Mammen Excellence in Thrombosis and Hemostasis Award - Young Investigator, 2013
  • AAMC Early Career Women Faculty Professional Development Seminar, 2012
  • Best Doctors in America, 2011-14
  • National Institutes of Health Pediatric Research Loan Repayment Program Renewals, Awarded in 2009 and 2011, 2007-13
  • Hemophilia and Thrombosis Research Society Career Development Award, 2007
  • American Society of Hematology Fellow Scholar Award, 2006
  • Wallace H. Coulter Foundation Scholar (awarded to the recipient of an ASH Scholar Award with the highest scored clinical/translational research application), 2006
  • American Society of Hematology Clinical Research Training Institute, 2005
  • Hemophilia and Thrombosis Research Society, Clinical Thrombosis Research Award, 2004
  • Mark A. Sperling Resident Research Award, Children's Hospital of Pittsburgh, 2003
  • Children's Hospital of Pittsburgh Primary Care Award, 2003
  • Region III Ambulatory Pediatric Association Research Award, 2002
  • Alpha Omega Alpha, 2000

Pediacast Interview: Von Willebrand Disease

Pediacast with Dr. Mike features Dr. Sarah O'Brien on the topic of Von Willebrand Disease.

Pediacast with Dr. Mike Patrick

Listen now »

Listen to Dr. O'Brien on PediaCast

PediaCast 166 * Von Willebrand Disease
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000